Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atrial Fibrillation; Stroke Prevention”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01947959
What this trial is testing

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Germany)

Who this might be right for
Venous ThrombosisPulmonary EmbolismAtrial Fibrillation+1 more
Bayer 665,533
Not applicableStudy completedNCT01090362
What this trial is testing

Global Anticoagulant Registry in the Field

Who this might be right for
Atrial Fibrillation
Thrombosis Research Institute 57,250
Large-scale testing (Phase 3)Study completedNCT01674647
What this trial is testing

Explore the Efficacy and Safety of Once-daily Oral Rivaroxaban for the Prevention of Cardiovascular Events in Subjects With Nonvalvular Atrial Fibrillation Scheduled for Cardioversion

Who this might be right for
Atrial Fibrillation
Bayer 1,504
Not applicableLooking for participantsNCT04559243
What this trial is testing

Left Atrial Appendage Closure as Secondary Prevention of Atrial Fibrillation-related Embolic Events

Who this might be right for
Non-valvular Atrial FibrillationEmbolic Stroke
Lifetech Scientific (Shenzhen) Co., Ltd. 579
Not applicableUnknownNCT04180605
What this trial is testing

Computational Simulation to Plan for Percutaneous Left Atrial Appendage Closure

Who this might be right for
Atrial FibrillationStroke Prevention
Rigshospitalet, Denmark 200
Not applicableStudy completedNCT02810509
What this trial is testing

Quality of Anticoagulation With Warfarin in Patient With Atrial Fibrillation for Secondary Stroke Prevention in Korea

Who this might be right for
Atrial FibrillationStroke
Inje University 1,814
Not applicableStudy completedNCT03374540
What this trial is testing

Rivaroxaban vs Warfarin for SPAF in Multi-morbid Patients

Who this might be right for
Nonvalvular Atrial Fibrillation
Bayer 78,517
Not applicableStudy completedNCT00861354
What this trial is testing

Home Monitoring for Atrial Fibrillation Using a Microlife Blood Pressure Monitor

Who this might be right for
Atrial Fibrillation
Microlife 150
Large-scale testing (Phase 3)Study completedNCT03273322
What this trial is testing

Assessment of Dual Antiplatelet Therapy Versus Rivaroxaban In Atrial Fibrillation Patients Treated With Left Atrial Appendage Closure

Who this might be right for
Atrial FibrillationAtrial AppendageHemorrhage
Assistance Publique - Hôpitaux de Paris 105
Post-approval studies (Phase 4)UnknownNCT02004509
What this trial is testing

Subclinical AtrIal FibrilLation and StrokE PreveNtion Trial

Who this might be right for
Atrial Fibrillation
InCor Heart Institute 2,054
Post-approval studies (Phase 4)Study completedNCT01288352
What this trial is testing

Early Treatment of Atrial Fibrillation for Stroke Prevention Trial

Who this might be right for
Atrial FibrillationStroke
Atrial Fibrillation Network 2,789
Not applicableStudy completedNCT02684981
What this trial is testing

Patient Convenience Study (RE-SONANCE)

Who this might be right for
Atrial FibrillationStroke
Boehringer Ingelheim 9,472
Not applicableUnknownNCT02635685
What this trial is testing

Clinical Decision Support for Stroke Prevention in Atrial Fibrillation

Who this might be right for
Cardiovascular DiseaseAtrial FibrillationStroke
University Hospital, Linkoeping 442,105
Not applicableStudy completedNCT02455102
What this trial is testing

Electronic Warning System for Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Insel Gruppe AG, University Hospital Bern 1,707
Post-approval studies (Phase 4)Looking for participantsNCT04642430
What this trial is testing

COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Ottawa Hospital Research Institute 3,018
Not applicableUnknownNCT03838341
What this trial is testing

Stand-alone Totally Thoracoscopic Left Atrial Appendage Occlusion Using AtriClip® Device in Non-valvular Atrial Fibrillation.

Who this might be right for
Stroke PreventionAtrial FibrillationSafety Issues
Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland 100
Not applicableUnknownNCT02147444
What this trial is testing

Evaluation of Effectiveness and Safety of Xa Inhibitor for the Prevention of Stroke And Systemic Embolism in a Nationwide Cohort of Japanese Patients Diagnosed as Non-valvular Atrial Fibrillation

Who this might be right for
Non-valvular Atrial Fibrillation
Tohoku University 7,000
Not applicableStudy completedNCT02690155
What this trial is testing

Real-world Comparative Effectiveness of Rivaroxaban Versus VKA

Who this might be right for
Atrial Fibrillation
Bayer 38,831
Not applicableNot Yet RecruitingNCT07598903
What this trial is testing

Pharmacy-based Opportunistic Atrial Fibrillation Screening Integrated With Emergency Services (NUMAPLUS-FA)

Who this might be right for
Atrial Fibrillation (Prevention of Stroke)Arrythmia, CardiacMass Screening+1 more
Centro de Emergencias Sanitarias 061 Andalucía 380
Large-scale testing (Phase 3)Study completedNCT02283294
What this trial is testing

Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation

Who this might be right for
Transient Ischemic AttackStrokeAtrial Fibrillation
University of South Florida 91
Next Page